Suppr超能文献

生长因子信号通路作为预防上皮性癌发生的靶点。

Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis.

机构信息

Division of Pharmacology & Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, Texas 78723-3092, USA.

出版信息

Mol Carcinog. 2011 Apr;50(4):264-79. doi: 10.1002/mc.20665. Epub 2010 Jul 20.

Abstract

Growth factor receptor (GFR) signaling controls epithelial cell growth by responding to various endogenous or exogenous stimuli and subsequently activating downstream signaling pathways including Stat3, PI3K/Akt/mTOR, MAPK, and c-Src. Environmental chemical toxicants and UVB irradiation cause enhanced and prolonged activation of GFR signaling and downstream pathways that contributes to epithelial cancer development including skin cancer. Recent studies, especially those with tissue-specific transgenic mouse models, have demonstrated that GFRs and their downstream signaling pathways contribute to all three stages of epithelial carcinogenesis by regulating a wide variety of biological functions including proliferation, apoptosis, angiogenesis, cell adhesion, and migration. Inhibiting these signaling pathways early in the carcinogenic process results in reduced cell proliferation and survival, leading to decreased tumor formation. Collectively, these studies suggest that GFR signaling and subsequent downstream signaling pathways are potential targets for the prevention of epithelial cancers including skin cancer.

摘要

生长因子受体(GFR)信号通过响应各种内源性或外源性刺激来控制上皮细胞的生长,随后激活包括 Stat3、PI3K/Akt/mTOR、MAPK 和 c-Src 在内的下游信号通路。环境化学毒物和 UVB 照射会导致 GFR 信号及其下游通路的增强和持续激活,从而促进上皮癌的发展,包括皮肤癌。最近的研究,特别是那些具有组织特异性转基因小鼠模型的研究,表明 GFR 及其下游信号通路通过调节广泛的生物学功能,包括增殖、凋亡、血管生成、细胞黏附和迁移,参与上皮癌发生的所有三个阶段。在致癌过程的早期抑制这些信号通路会导致细胞增殖和存活减少,从而减少肿瘤形成。总的来说,这些研究表明,GFR 信号及其随后的下游信号通路是预防包括皮肤癌在内的上皮癌的潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd7/3005141/15daec3952c3/nihms-217435-f0001.jpg

相似文献

引用本文的文献

2
The signaling landscape of insulin-like growth factor 1.胰岛素样生长因子1的信号转导格局
J Biol Chem. 2025 Jan;301(1):108047. doi: 10.1016/j.jbc.2024.108047. Epub 2024 Dec 3.
3
Engineering growth factor ligands and receptors for therapeutic innovation.用于治疗创新的工程化生长因子配体和受体。
Trends Cancer. 2024 Dec;10(12):1131-1146. doi: 10.1016/j.trecan.2024.09.006. Epub 2024 Oct 10.
9
Repurposing anticancer drugs for the management of COVID-19.重新利用抗癌药物来治疗新冠肺炎。
Eur J Cancer. 2020 Dec;141:40-61. doi: 10.1016/j.ejca.2020.09.014. Epub 2020 Sep 22.

本文引用的文献

3
Crosstalk in Met receptor oncogenesis.Met 受体致癌作用中的串扰。
Trends Cell Biol. 2009 Oct;19(10):542-51. doi: 10.1016/j.tcb.2009.07.002. Epub 2009 Sep 14.
7
The role of Src in solid tumors.Src在实体瘤中的作用。
Oncologist. 2009 Jul;14(7):667-78. doi: 10.1634/theoncologist.2009-0009. Epub 2009 Jul 6.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验